Search Results - "Mazariegos, G V"

Elective Liver Transplantation for the Treatment of Classical Maple Syrup Urine Disease by Strauss, K. A., Mazariegos, G. V., Sindhi, R., Squires, R., Finegold, D. N., Vockley, G., Robinson, D. L., Hendrickson, C., Virji, M., Cropcho, L., Puffenberger, E. G., McGhee, W., Seward, L. M., Morton, D. H.

“…An 8.5‐year‐old girl with classical maple syrup urine disease (MSUD) required liver transplantation for hypervitaminosis A and was effectively cured of MSUD…”
Get full text

Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: A case series by Shellmer, D. A., DeVito Dabbs, A., Dew, M. A., Noll, R. B., Feldman, H., Strauss, K. A., Morton, D. H., Vockley, J., Mazariegos, G. V.

“…Shellmer DA, DeVito Dabbs A, Dew MA, Noll RB, Feldman H, Strauss KA, Morton DH, Vockley J, Mazariegos GV. Cognitive and adaptive functioning after liver…”
Get full text

Long‐term Management of the Liver Transplant Patient: Recommendations for the Primary Care Doctor by McGuire, B. M., Rosenthal, P., Brown, C. C., Busch, A. M. H., Calcatera, S. M., Claria, R. S., Hunt, N. K., Korenblat, K. M., Mazariegos, G. V., Moonka, D., Orloff, S. L., Perry, D. K., Rosen, C. B., Scott, D. L., Sudan, D. L.

“…No official document has been published for primary care physicians regarding the management of liver transplant patients. With no official source of…”
Get full text

The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi‐Site Study by Shemesh, E., Bucuvalas, J. C., Anand, R., Mazariegos, G. V., Alonso, E. M., Venick, R. S., Reyes‐Mugica, M., Annunziato, R. A., Shneider, B. L.

“…Nonadherence to immunosuppressant medications is a leading cause of poor long‐term outcomes in transplant recipients. The Medication Level Variability Index…”
Get full text

Weaning of immunosuppression in liver transplant recipients by MAZARIEGOS, G. V, REYES, J, MARINO, I. R, DEMETRIS, A. J, FLYNN, B, IRISH, W, MCMICHAEL, J, FUNG, J. J, STARZL, T. E

“…Immunosuppression has been sporadically discontinued by noncompliant liver allograft recipients for whom an additional 4 1/2 years of follow-up is provided…”
Get full text

Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus by KUDDUS, R, PATZER, J. F, LOPEZ, R, MAZARIEGOS, G. V, MEIGHEN, B, KRAMER, D. J, RAO, A. S

“…The potential risk of transmission of porcine endogenous retroviruses (PERV) from xenogeneic donors into humans has been widely debated. Because we were…”
Get full text

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease by GREEN, M, CACCIARELLI, T. V, MAZARIEGOS, G. V, SIGURDSSON, L, LIRON QU, ROWE, D. T, REYES, J

“…Few data are available describing the natural history of the Epstein-Barr virus (EBV) viral load after the diagnosis of EBV-associated posttransplant…”
Get full text

Liver and Intestine Transplantation in the United States 1998–2007 by Berg, C. L., Steffick, D. E., Edwards, E. B., Heimbach, J. K., Magee, J. C., Washburn, W. K., Mazariegos, G. V.

“…Liver transplantation numbers in the United States remained constant from 2004 to 2007, while the number of waiting list candidates has trended down. In 2007,…”
Get full text

Intestine Transplantation in the United States, 1999–2008 by Mazariegos, G. V., Steffick, D. E., Horslen, S., Farmer, D., Fryer, J., Grant, D., Langnas, A., Magee, J. C.

“…Improving short‐term results with intestine transplantation have allowed more patients to benefit with nearly 700 patients alive in the United States with a…”
Get full text

Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy by CACCIARELLI, T. V, GREEN, M, JAFFE, R, MAZARIEGOS, G. V, JAIN, A, FUNG, J. J, REYES, J

“…Posttransplant lymphoproliferative disease (PTLD) after pediatric liver transplantation has been associated with high mortality rates. The present study…”
Get full text

Late Graft Loss or Death in Pediatric Liver Transplantation: An Analysis of the SPLIT Database by Soltys, K. A., Mazariegos, G. V., Squires, R. H., Sindhi, R. K., Anand, R.

“…Late graft loss (LGL) and late mortality (LM) following liver transplantation (LT) in children were analyzed from the studies of pediatric liver…”
Get full text

Intrahepatic chemoembolization in unresectable pediatric liver malignancies by ARCEMENT, Christopher M, TOWBIN, Richard B, MEZA, Manuel P, GERBER, David A, KAYE, Robin D, MAZARIEGOS, George V, CARR, Brian I, REYES, Jorge

“…To determine the effectiveness of a new multidisciplinary approach using neoadjuvant intrahepatic chemoembolization (IHCE) and liver transplant (OLTx) in…”
Get full text

Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment by McGhee, W., Mazariegos, G.V., Sindhi, R., Abu-Elmagd, K., Reyes, J.

Get full text

Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence by Reyes, Jorge D., Carr, Brian, Dvorchik, Igor, Kocoshis, Samuel, Jaffe, Ronald, Gerber, David, Mazariegos, George V., Bueno, Javier, Selby, Rick

“…Objective: To describe our experience with total hepatectomy and liver transplantation as treatment for primary hepatoblastoma (HBL) and hepatocellular…”
Get full text

Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up by Mazariegos, G.V., Reyes, J., Marino, I., Flynn, B., Fung, J.J., Starzl, T.E.

Get full text

Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria by Shakil, A. Obaid, Kramer, David, Mazariegos, George V., Fung, John J., Rakela, Jorge

“…Acute liver failure(ALF)is an uncommon condition associated with high morbidity and mortality. We performed a retrospective analysis of patients evaluated for…”
Get full text

Fulminant hepatic failure by Shakil, A O, Mazariegos, G V, Kramer, D J

“…Fulminant hepatic failure is a disease of varied causes and a high mortality rate. A sudden onset, jaundice, hepatic encephalopathy, and multiorgan failure are…”
Get more information

An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy by CACCIARELLI, T. V, DVORCHIK, I, MAZARIEGOS, G. V, GERBER, D, JAIN, A. B, FUNG, J. J, REYES, J

“…The present study analyzes pretransplantation variables associated with long-term liver allograft survival in 278 children who underwent transplantation under…”
Get full text

Pediatric transplantation by Reyes, J, Mazariegos, G V

“…Advances in organ preservation, surgical technique, and postoperative care have permitted the rapid development of liver transplantation in children…”
Get more information

Early complications after orthotopic liver transplantation by Mazariegos, G V, Molmenti, E P, Kramer, D J

“…The cost and impact of early post-transplant complications continue to be high. Diagnosis and management involves a high index of suspicion, rapid diagnostic…”
Get more information